Dailipharma

Active

Private limited companyfounded 2020active for 6 yearsDoorniksestraat(Kor) 27, 8500 Kortrijk, BelgiumKBO/BCE: BE 0755.861.612

Summary

The computed 12-month bankruptcy probability of Dailipharma is 1.8% (moderate). The 2025 annual accounts show equity of €74,467 and a net result of €3,297. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 40% of 22,080 sector peers (NACE 47, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

DailipharmaActiveChecked score 54/100

Risk analysis Report Compare

Directors

1 director, last change in 2026

Board 1

Jan Helskens Consulting

Director · since 28-08-2026 · Private limited company · permanent representative: HELKSENS Jan

Current

Permanent representatives 1

HELKSENS Jan

Permanent representative · since 28-08-2026 · for Jan Helskens Consulting

Current

Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Not every act has been read: a resignation may still be missing

3 of this company's 6 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

2 people since 2026, 1 in office

All 2 In office 1 Ended 1

Board
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
Jan Helskens Consulting	Director, from 28-08-2026 to date
Louis VANHOVE	Director, until 06-07-2026

See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years

28-08-2026 Capital stated in the deed · 450,000 shares